Bon Natural Life Limited (BON)
NasdaqCM: BON
· Echtzeitkurs · USD
1.15
+0.00 (0.00%)
Zum Schluss: Aug 13, 2026, 11:57 AM
1.12
-2.52%
Nachbörslich: 4:10 PM
Bon Natural Life Limited (BON) Stock Price, Analysis & Data
0.00% (1D)
| Geld | 0.78 |
| Marktkapitalisierung | 11.69 Mio |
| Umsatz (TTM) | 18.67 Mio |
| Nettogewinn (TTM) | -1.99 Mio |
| Beta | -0.26 |
| EPS (ttm) | -0.72 |
| KGV (TTM) | n/a |
| Forward-KGV | 1.98 |
| KBV (TTM) | 0.12 |
| KUV (TTM) | 0.63 |
| Earnings Date | n/a |
| Brief | 1.51 |
| Volumen | 4,859 |
| Ø Vol. (20D) | 15,683 |
| Eröffnung | 1.15 |
| Vortagesschluss | 1.15 |
| Tagesspanne | 1.10 - 1.15 |
| 52-Wk Range | 1.05 - 3.40 |
| Analyst | n/a |
| Kursziel | n/a |
| Dividenden | n/a |
| Ex-Dividenden-Datum | n/a |
Über BON
Bon Natural Life Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China, Europe, North America, and the Middle East. The company offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks...
Branche Specialty Chemicals
Sektor Basic Materials
IPO Datum Jun 24, 2021
Mitarbeiter 96
Börse NasdaqCM
Tickersymbol BON
Website https://www.bnlus.com
Finanzielle Entwicklung
Im Jahr 2025 betrug der Umsatz von Bon Natural Life 18.67 Mio, ein Rückgang von -21.7% im Vergleich zum Vorjahr (23.84 Mio). Der Gewinn lag bei -1.99 Mio, ein Rückgang von -600.98 %.
Finanzberichte
